Journal of Diabetes and Its Complications
Volume 20, Issue 2 , Pages 121-132, March 2006

The metabolic syndrome:☆

Prevalence, CHD risk, and treatment

  • Cinzia Sarti

      Affiliations

    • National Public Health Institute, Helsinki, Finland
    • Corresponding Author InformationCorresponding author. Department of Epidemiology and Health Promotion, National Public Health Institute, Mannerheimintie 166, Helsinki FIN-00300, Finland. Tel.: +358 505 831305; fax: +358 947 448338.
    • ,
  • John Gallagher

      Affiliations

    • AstraZeneca SA, Zaventem, Belgium

Received 4 February 2004; received in revised form 1 June 2005; accepted 7 June 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Funding for the article was supported by AstraZeneca.

PII: S1056-8727(05)00083-8

doi:10.1016/j.jdiacomp.2005.06.014

Journal of Diabetes and Its Complications
Volume 20, Issue 2 , Pages 121-132, March 2006

Article Tools

* Image Usage & Resolution